Tokyo, Japan
September 18-19, 2021

Hoshi University
2-4-41 Ebara, Shinagawa-ku, Tokyo, Japan

The Joint Symposium will be held in conjunction with the 67th Annual Meeting of JSP

Symposium Outline

Overview of the 11th JSP-CSP-KSP Joint Symposium on Pharmacognosy (11th JCK) in conjunction with the 67th Annual Meeting of Pharmacognosy (67th JSP)

Venue: Virtual Conference
(Host: Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan)
Schedule: September 18 to 19, 2021 (67th JSP: September 19-20, 2021)

Hosted by: The Japanese Society of Pharmacognosy in cooperation with CSP and KSP
Supported by:
Japan Kampo Medicines Manufacturers Association (JKMA)
Tokyo Crude Drug Association (TCDA) 
Japan Natural Medicines Association (JNMA)

The executive committee of 11th JCK:
Contact Person (Dr.  Takashi Morota) Tsumura &CO., CMC Research & Development Laboratories
Chair Person (Prof. Koji Ichinose) Musashino University, Research Institute of Pharmaceutical Sciences and Faculty of Pharmacy

Special Symposium ~Industries organized symposium~

1) Date: Sep. 19th, 2021 (Mon), 15:00~17:00

2) Theme of the symposium:
Quality Assurance & Therapeutic Evidence of Traditional East Asian Medicinal (TEAM) Products
– Current and Future Trends in TEAM Products for an Aging Society –  

3) Organizers:
Dr. Takashi Morota: Corresponding (Chair of International Committee, JKMA)
Dr. Sakae Yamanouchi (Chair of Academic Committee, TCDA)
Dr. Yutaka Yamamoto (Chair of Technical Committee, JMPF)

4) Summary:
Sustainable use of high-quality traditional medicines is a very important issue for the three countries facing aging societies.
This symposium will organize the three invited lectures highlighting typical Traditional East Asian Medicinal Products (TEAM) in each country, especially for the elderly. The topics include clinical and/or non-clinical evidences as well as quality assurance of the products. These lectures will be followed by a Q & A session, where we aim to discuss the quality standardization (QS) which is utmost importance for clinical reproducibility of medicinal drugs. Therefore, the speakers will be expected to indicate paradigm and future concept of implementation of QS of the subjected traditional medicines consisting of multiple chemical ingredients. The QS issues involve GAP, GMP, quality standards, standardization of crude drugs VS extract and quantification by marker components.

5) Speakers:
Each of the three societies will have their speaker present a 30 min lecture. The lecture will be followed by a 30 min Q&A session.

For further information, contact to: 
The 11th JSP-CSP-KSP Joint Symposium Executive Committee Office
c/o PCO
120 Kosugi, Toyama-shi, Toyama 939-8063
TEL: +81-76-461-7028 FAX: +81-76-428-9156